Latest News about AGIO
Recent news which mentions AGIO
Agios Pharmaceuticals's Return On Capital Employed Overview
November 17, 2022
Tickers
AGIO
From Benzinga
Europe Approves Agios Pharma's Mitapivat For Adult Pyruvate Kinase Deficiency Patients
November 11, 2022
Tickers
AGIO
From Benzinga
Why Snap Shares Jumped 7%; Here Are 75 Biggest Movers From Yesterday
September 02, 2022
From Benzinga
Why Okta Is Trading Lower By Over 32%, Here Are 58 Stocks Moving In Thursday's Mid-Day Session
September 01, 2022
From Benzinga
Nutanix, Five Below And Some Other Big Stocks Moving Higher On Thursday
September 01, 2022
From Benzinga
Looking Into Agios Pharmaceuticals Return On Capital Employed
August 15, 2022
Tickers
AGIO
From Benzinga
From Benzinga
From Benzinga
From Benzinga
U.S. Stock Futures Higher; All Eyes On Inflation Data
July 13, 2022
From Benzinga
From Benzinga
From Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
From Benzinga
From Benzinga
From Benzinga
The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company
February 24, 2022
From Benzinga
What 4 Analyst Ratings Have To Say About Agios Pharmaceuticals
February 22, 2022
Tickers
AGIO
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
The Daily Biotech Pulse: Regeneron-Sanofi Halt Late-Stage Dupixent Study, Agios Gets FDA Nod, Safety Scare For GSK's RSV Vaccine, Shockwave Jumps On Earnings
February 18, 2022
From Benzinga
FDA Approves Agios' Mitapivat As First Disease-Modifying Therapy For Genetic Blood Disorder
February 18, 2022
Tickers
AGIO
From Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
From Benzinga
3 Desirable Drug Stocks With Very Promising Pipelines
February 16, 2022
From InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.